204 related articles for article (PubMed ID: 16777249)
1. Value of primary care electrocardiography for the prediction of left ventricular systolic dysfunction in patients with suspected heart failure.
Lim TK; Collinson PO; Celik E; Gaze D; Senior R
Int J Cardiol; 2007 Jan; 115(1):73-4. PubMed ID: 16777249
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of the B type natriuretic peptide, electrocardiography, and portable echocardiography for the assessment of patients from the community with suspected heart failure.
Lim TK; Dwivedi G; Hayat S; Collinson PO; Senior R
Echocardiography; 2007 Mar; 24(3):228-36. PubMed ID: 17313633
[TBL] [Abstract][Full Text] [Related]
3. Ruling out heart failure in primary-care: the cost-benefit of pre-screening using NT-proBNP and QRS width.
Goode KM; Clark AL; Cleland JG
Int J Cardiol; 2008 Nov; 130(3):426-37. PubMed ID: 18178273
[TBL] [Abstract][Full Text] [Related]
4. What is the most cost-effective strategy to screen for left ventricular systolic dysfunction: natriuretic peptides, the electrocardiogram, hand-held echocardiography, traditional echocardiography, or their combination?
Galasko GI; Barnes SC; Collinson P; Lahiri A; Senior R
Eur Heart J; 2006 Jan; 27(2):193-200. PubMed ID: 16267076
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.
Ng LL; Pathik B; Loke IW; Squire IB; Davies JE
Am Heart J; 2006 Jul; 152(1):94-101. PubMed ID: 16824837
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular dysfunction screening in hypertensive patients with N-terminal pro-B-type natriuretic peptide and electrocardiogram.
Limkakeng AT; Drake W; Mani G; Freeman D; Best R; Newby LK; Chandra A
Am J Emerg Med; 2012 Jan; 30(1):214-7. PubMed ID: 21185671
[TBL] [Abstract][Full Text] [Related]
7. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide].
Tarantini L; Cioffi G; Di Lenarda A; Valle R; Pulignano G; Del Sindaco D; Frigo G; Soravia G; Tessier R; Catania G
G Ital Cardiol (Rome); 2008 Dec; 9(12):835-43. PubMed ID: 19119693
[TBL] [Abstract][Full Text] [Related]
8. Independent value of echocardiography and N-terminal pro-natriuretic Peptide for the prediction of major outcomes in patients with suspected heart failure.
Lim TK; Hayat SA; Gaze D; Celik E; Collinson P; Senior R
Am J Cardiol; 2007 Sep; 100(5):870-5. PubMed ID: 17719336
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of B-type natriuretic peptide for validation of a heart failure register in primary care.
Bhatia GS; Sosin MD; Stubley J; Patel JV; Hughes EA; Gibbs R; Davis RC
BMC Cardiovasc Disord; 2007 Jul; 7():23. PubMed ID: 17663777
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
Romano S; Necozione S; Guarracini L; Fratini S; Cisternino P; di Orio F; Penco M
J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
[TBL] [Abstract][Full Text] [Related]
11. Changes in plasma N-terminal proBNP levels and ventricular filling pressures during intensive unloading therapy in elderly with decompensated congestive heart failure and preserved left ventricular systolic function.
Cioffi G; Tarantini L; Stefenelli C; Azzetti G; Marco R; Carlucci S; Furlanello F
J Card Fail; 2006 Oct; 12(8):608-15. PubMed ID: 17045179
[TBL] [Abstract][Full Text] [Related]
12. Screening for left ventricular systolic dysfunction using GP-reported ECGs.
Goudie BM; Jarvis RI; Donnan PT; Sullivan FM; Pringle SD; Jeyaseelan S; Struthers AD
Br J Gen Pract; 2007 Mar; 57(536):191-5. PubMed ID: 17359605
[TBL] [Abstract][Full Text] [Related]
13. [The clinical value of B-type natriuretic peptide in the diagnosis of left heart failure].
Zhao XY; Yang YJ; Zhang J; Dang AM; Ni XH; Huang J; Kang S; Ma WH; Zhao DY
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1165-9. PubMed ID: 16796855
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of acoustic cardiography to resolve ambiguous values of B-type natriuretic Peptide levels in patients with suspected heart failure.
Zuber M; Kipfer P; Attenhofer Jost CH
Am J Cardiol; 2007 Sep; 100(5):866-9. PubMed ID: 17719335
[TBL] [Abstract][Full Text] [Related]
15. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: results of the UK natriuretic peptide study.
Zaphiriou A; Robb S; Murray-Thomas T; Mendez G; Fox K; McDonagh T; Hardman SM; Dargie HJ; Cowie MR
Eur J Heart Fail; 2005 Jun; 7(4):537-41. PubMed ID: 15921792
[TBL] [Abstract][Full Text] [Related]
17. Combined use of amino terminal-pro-brain natriuretic peptide levels and QRS duration to predict left ventricular systolic dysfunction in patients with dyspnea.
Sakhuja R; Chen AA; Anwaruddin S; Baggish AL; Januzzi JL
Am J Cardiol; 2005 Jul; 96(2):263-6. PubMed ID: 16018854
[TBL] [Abstract][Full Text] [Related]
18. Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study.
de Lemos JA; McGuire DK; Khera A; Das SR; Murphy SA; Omland T; Drazner MH
Am Heart J; 2009 Apr; 157(4):746-53.e2. PubMed ID: 19332205
[TBL] [Abstract][Full Text] [Related]
19. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction.
Goetze JP; Mogelvang R; Maage L; Scharling H; Schnohr P; Sogaard P; Rehfeld JF; Jensen JS
Eur Heart J; 2006 Dec; 27(24):3004-10. PubMed ID: 17118955
[TBL] [Abstract][Full Text] [Related]
20. Electrocardiograph and chest X-ray in prediction of left ventricular systolic dysfunction.
Basnet BK; Manandhar K; Shrestha R; Shrestha S; Thapa M
JNMA J Nepal Med Assoc; 2009; 48(176):310-3. PubMed ID: 21105556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
